Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-3255
Sander, P; Böttger, E C; Springer, B; Steinmann, B; Rezwan, M; Stavropoulos, E; Colston, M J (2003). A recA deletion mutant of Mycobacterium bovis BCG confers protection equivalent to that of wild-type BCG but shows increased genetic stability. Vaccine, 21(27-30):4124-4127.
- Registered users only
The widely used vaccine against tuberculosis, BCG, shows evidence of genetic instability. It has undergone major genetic rearrangements resulting in deletion and duplication of segments of its chromosome. In order to produce a BCG strain with more favourable genetic properties, we inactivated the recA gene. Targeted deletion of the recA gene of BCG resulted in a complete loss of recombination between homologous, chromosomally-located sequences, as well as between plasmid- and chromosomally-located sequences. The deltarecA mutant BCG was as effective as the wild-type in conferring protection in mice against an intravenous challenge with virulent Mycobacterium tuberculosis, indicating that the loss of an SOS response-mediated DNA repair mechanism did not compromise the immunological properties of BCG. The availability of a genetically stable, fully immunogenic BCG is important for the future development of BCG as a live vaccine.
|Item Type:||Journal Article, refereed, original work|
|Communities & Collections:||04 Faculty of Medicine > Institute of Medical Microbiology|
|DDC:||570 Life sciences; biology|
610 Medicine & health
|Deposited On:||22 Aug 2008 12:12|
|Last Modified:||27 Nov 2013 23:47|
|Citations:||Web of Science®. Times Cited: 6|
Scopus®. Citation Count: 7
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page